Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Journal of Virology
|
August 17, 2006
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding
Ania M Owsianka, Judith M Timms, Alexander W Tarr, et al.
Pharmaceutics
|
December 23, 2022
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics
Michel Siegel, Guido Steiner, Linnea C Franssen, et al.
Frontiers in Immunology
|
September 30, 2022
HLAII peptide presentation of infliximab increases when complexed with TNF
Andrea Casasola-LaMacchia, Robert Joseph Seward, Sophie Tourdot, et al.
Frontiers in Immunology
|
September 4, 2024
Development and characterization of dendritic cell internalization and activation assays contributing to the immunogenicity risk evaluation of biotherapeutics
Michel Siegel, Aman Padamsey, Anna-Lena Bolender, et al.
Journal of Innate Immunity
|
May 24, 2014
Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
Mohamed R Hamed, Richard J P Brown, Carsten Zothner, et al.
Mabs
|
May 17, 2013
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
Mischa R Müller, Kenneth Saunders, Christopher Grace, et al.
Antiviral Therapy
|
April 17, 2012
Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCV
M Victoria Flores, Timothy P Hickling, Sasha Sreckovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 2, 2015
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies
Sue Townsend, Brian J Fennell, James R Apgar, et al.
Arthritis and Rheumatism
|
October 31, 2007
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril
A E Gliddon, C J Doré, C M Black, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 19, 2019
A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
Andrzej M Kierzek, Timothy P Hickling, Isabel Figueroa, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Journal of Virology
|
August 17, 2006
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding
Ania M Owsianka, Judith M Timms, Alexander W Tarr, et al.
Pharmaceutics
|
December 23, 2022
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics
Michel Siegel, Guido Steiner, Linnea C Franssen, et al.
Frontiers in Immunology
|
September 30, 2022
HLAII peptide presentation of infliximab increases when complexed with TNF
Andrea Casasola-LaMacchia, Robert Joseph Seward, Sophie Tourdot, et al.
Frontiers in Immunology
|
September 4, 2024
Development and characterization of dendritic cell internalization and activation assays contributing to the immunogenicity risk evaluation of biotherapeutics
Michel Siegel, Aman Padamsey, Anna-Lena Bolender, et al.
Journal of Innate Immunity
|
May 24, 2014
Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
Mohamed R Hamed, Richard J P Brown, Carsten Zothner, et al.
Mabs
|
May 17, 2013
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
Mischa R Müller, Kenneth Saunders, Christopher Grace, et al.
Antiviral Therapy
|
April 17, 2012
Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCV
M Victoria Flores, Timothy P Hickling, Sasha Sreckovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 2, 2015
Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies
Sue Townsend, Brian J Fennell, James R Apgar, et al.
Arthritis and Rheumatism
|
October 31, 2007
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril
A E Gliddon, C J Doré, C M Black, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 19, 2019
A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
Andrzej M Kierzek, Timothy P Hickling, Isabel Figueroa, et al.
Page
of 10